Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity

CONTEXT: Treatment of advanced and recurrent endometrial cancer (EC) is still an unmet need for oncologists and gynecologic oncologists. The Cancer Genome Atlas Research Network (TCGA) recently provided a new genomic classification, dividing EC in four subgroups. Two types of EC, the polymerase epsi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Mittica, Gloria, Ghisoni, Eleonora, Giannone, Gaia, Aglietta, Massimo, Genta, Sofia, Valabrega, Giorgio
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2017
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685772/
https://ncbi.nlm.nih.gov/pubmed/29163851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20042
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge